Evaluating implementation of NCCN guideline-directed genetic screening recommendations for patients with pancreatic ductal adenocarcinoma.

导出原文传递

翻译打印收藏纠错

第一作者： Aditya K,Ghosh

第一单位： Northeast Georgia Medical Center, Gainesville, GA, USA. aditya.ghosh@nghs.com.

作者： Aditya K,Ghosh ^[1] ; Sheena,Bhushan ^[2] ; Oluseyi,Abidoye ^[3] ; Shane S,Robinson ^[2] ; Ania Izabela,Rynarzewska ^[4] ; Devi,Sampat ^[5]

作者单位： Northeast Georgia Medical Center, Gainesville, GA, USA. aditya.ghosh@nghs.com. ^[1] Northeast Georgia Medical Center, Gainesville, GA, USA. ^[2] Mayo Clinic Hospital, Phoenix, AZ, USA. ^[3] Georgia College and State University, Milledgeville, GA, USA. ^[4] Longstreet Clinic Cancer Center, Gainesville, GA, USA. ^[5]

关键词 Genetic testing NCCN Pancreatic ductal adenocarcinoma

主题词人类(Humans);回顾性研究(Retrospective Studies);癌, 胰腺管(Carcinoma, Pancreatic Ductal);胰腺肿瘤(Pancreatic Neoplasms);基因检测(Genetic Testing)

DOI 10.1007/s10552-023-01825-5

PMID 38015388

发布时间 2024-03-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交